couter

CONConcentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc. (CON) operates as a provider of occupational health services, offering a range of clinical and administrative services to employers and employees. The next catalyst is Nov 6, 2026 — Q3 2026 Earnings Release, which will test the company’s ability to sustain revenue growth and deliver on its raised guidance. The event will also provide insight into the impact of recent regulatory and macroeconomic shifts on its core business.

  • Revenue grew 13.9% YoY to $2.30B, with net income of $214.53M and diluted EPS of $0.51.
  • Free cash flow (TTM) reached $297.06M, with a net margin of 9.3% and a debt-to-equity ratio of 3.98x.
  • Shareholders’ equity stands at $393.28M, with a strong cash flow position supporting both operational needs and shareholder returns.
Nov 2, 2026 — CMS Medicare Physician Fee Schedule Final Rule
Chart by TradingView

The schedule

  • Mon2Nov

    The final rule tests whether the company can secure favorable reimbursement rates under CMS, which directly impacts revenue and cash flow. This differs from the last rule, where the company faced margin compression due to lower mix.

  • Fri6Nov

    The earnings release will test whether the company can maintain its guidance and margin stability, with a focus on the mix of revenue streams and cash flow generation. This differs from the last print where the guidance was overly optimistic, leading to a sharp correction.

  • Tue9Feb

    This release will test the company's ability to deliver on its full-year guidance and demonstrate improved operational efficiency. The last print showed a weak guidance reset, which led to a bearish outcome, so the focus will be on whether the current guidance is more realistic and supported by the underlying business.

  • Thu6May

    This release will test the company's ability to sustain its guidance and demonstrate progress in its cost-cutting initiatives. The last print showed a weak guidance reset, which led to a bearish outcome, so the focus will be on whether the current guidance is more realistic and supported by the underlying business.

  • Thu5Aug

    This release will test the company's ability to deliver on its full-year guidance and demonstrate improved operational efficiency. The last print showed a weak guidance reset, which led to a bearish outcome, so the focus will be on whether the current guidance is more realistic and supported by the underlying business.

  • Wed11Aug

    The investor event will test the company's ability to communicate its strategic priorities and financial outlook, with a focus on how it plans to navigate macroeconomic headwinds and maintain cash flow stability. This event will also provide insight into management's confidence in the current guidance and its ability to execute on long-term growth initiatives.

  • Thu9Sep

    The news release will test the company's ability to provide actionable updates on its business performance, regulatory developments, and any strategic shifts that could impact its financial trajectory. This will be a critical moment to assess whether the company is making progress on its cost-cutting goals and maintaining its cash flow generation.

  • Fri5Nov

Past

  • Thu6Aug

    Actual outcome: Bear · $22.67 at outcome

    Stock fell 25.8% from event to outcome date, aligning with the bear trajectory.

    Market reaction to Concentra's Q2 performance and midyear guidance updates.

  • Thu7May

    Actual outcome: Bull · $24.89 at outcome

    Concentra Group delivered strong Q1 2026 results, beating revenue estimates and reporting EPS that met or slightly beat expectations. The company also declared a cash dividend and raised its full-year 2026 guidance. Despite these bullish fundamental drivers, shares remained flat, likely because the stock was already trading near 52-week highs and the market had largely priced in the positive performance.

  • Wed25Mar

    Actual outcome: Mixed · $21.61 at outcome

    The Federal Reserve's monetary policy decision and updated interest rate path initially prompted a slight 1.4% dip in the stock. However, the market ultimately digested the Fed's forward guidance and rate outlook as favorable for the macroeconomic environment, sparking a sustained rally that drove the stock well past the bull target over the following months.

  • Thu26Feb

    Actual outcome: Mixed · $23.56 at outcome

    Concentra Group reported strong Q4 2025 results, delivering earnings of $0.27-$0.28 per share that met or topped estimates alongside a revenue beat. Although the stock's initial reaction was relatively flat, dipping 1.1% in the days immediately following the event, the solid fundamental performance and positive analyst recommendations ultimately drove shares steadily higher over the following months to surpass the $24.50 bull target.

Scouting Reports